Tris Pharma INC
At a glance
Employees500+
In business sinceNot reported
HeadquartersMonmouth Junction, NJ
US patents52
SAM.gov UEINVJMJ89DAG58
CAGE code6E8S1
Incorporated inNJ
Supplier designations
For Profit OrganizationManufacturer of GoodsMinority Owned Business
Self-certified by the company in its SAM.gov registration
Patents
52 US patents granted 2011–2025, 16 of them in the five years to SEP 2025.
Pharmaceuticals 52
- Pharmaceutical composition comprising GHB gastro-retentive raft forming systems having trigger pulse drug releaseUS 12,201,720 · granted JAN 21, 2025
- Extended release amphetamine tabletsUS 12,076,441 · granted SEP 3, 2024
- Benzonatate modified release solid tablets and capsulesUS 11,938,224 · granted MAR 26, 2024
- Liquid clonidine extended release compositionUS 11,918,689 · granted MAR 5, 2024
- Benzonatate modified release solid tablets and capsulesUS 11,890,267 · granted FEB 6, 2024
Newest 5 shown · Granted to Tris Pharma INC · PatentsView (USPTO), data through SEP 30, 2025 · CC BY 4.0
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Tris Pharma INC | Monmouth Junction | NJ | 500+ | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.